Skip to main content

25 January 2026

Last updated: Friday 23 January 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Direct cell reprogramming: Mogrify and Astellas to address hearing loss

Wednesday 14 September 2022

Interviewee/Contributor

Louise Modis

Organisation

Mogrify Ltd

Technology for direct cell reprogramming

Tuesday 10 September 2019

Interviewee/Contributor

Julian Gough

Organisation

Mogrify Ltd

Organisations

vasopharm GmbH
Cohesion Bureau
The Pioneer Group
ERA Consulting (UK) Ltd
AM-Pharma BV
Evernow Publishing Ltd
Intercell AG
Max-Planck- Innovation GmbH
University of Pennsylvania, Perelman School of Medicine
Lawford Davies Denoon

Interviewees and Contributers

Sarah Bramley
Herve Brailly
Anders Månsson
Johannes Jensen
Richard Godfrey
Oumeya Adjali
Frank Carr
Richard Francis
Paul Thompson
Selema Akuiyibo

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

German biotech DISCO Pharmaceuticals appoints CEO

Monday 19 January 2026

argenx in CEO transition

Monday 19 January 2026

PureTech Health appoints CEO

Monday 19 January 2026

New CEO at Tacalyx

Monday 19 January 2026

Tubulis appoints oncology expert as CMO

Monday 19 January 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form